Rebecca Schaefer is a partner at the firm’s Research Triangle Park office. She is a member of the health care practice group, focusing her practice on healthcare regulatory and transactional matters. Ms. Schaefer has specialized knowledge of issues affecting academic medical centers, including those related to faculty practices, clinical research, mission support, governance and privacy. She provides counseling to health systems, physician practice groups and in-house pharmacies related to strategic affiliations, joint ventures, and compliance matters.
Prior to joining the firm, Ms. Schaefer served as an associate university counsel at The University of North Carolina at Chapel Hill, where she was the senior health care attorney for the UNC School of Medicine, UNC Faculty Physicians, and other health affairs schools. In this capacity, Ms. Schaefer advised campus and school-based leadership on myriad regulatory, transactional, institutional policy, and governance matters. Ms. Schaefer has counseled clients in the areas of fraud and abuse, privacy, human subjects research, and life sciences regulation. Her transactional experience includes joint ventures and physician practice acquisitions, as well as professional service, academic affiliation, timeshare, and data use agreements. Ms. Schaefer has drafted and counseled on faculty physician employment matters, including physician compensation plans, employment agreements, and restrictive covenants. Overall, her work for the university applied health care regulatory and transactional expertise to structure and facilitate various opportunities that furthered the patient care, clinical research, and medical education missions of the institution. Prior to UNC-Chapel Hill, Ms. Schaefer was in private practice with a large firm in Washington, D.C. representing clients from various sectors of the health care industry – including hospitals, medical management companies, physician groups, pharmaceutical and medical device companies, patient advocacy groups, and trade associations – on matters such as clinical trial agreements, regulatory compliance counseling, health care transactional due diligence, and the research, analysis, and compilation of legal and policy positions to comment on various agencies’ rulemaking on behalf of clients
More Legal and Business Bylines From Rebecca M. Schaefer
- Biden Administration Seeks to Establish New US $6.5 Billion Health Research Agency to Target Key Disease Areas - (Posted On Thursday, April 15, 2021)
- What AMCs May Expect in Health Care Policy Priorities from the New Congress and the Biden Administration [PODCAST] - (Posted On Thursday, February 18, 2021)
- The Tortoise and the Hare? HIPAA Joins the Regulatory Sprint to Coordinated Care - (Posted On Tuesday, December 22, 2020)
- COVID-19: Frontline University Perspective on the Pandemic’s Disruption to Ongoing Research, and Public Policy Projections for a Federal Response [PODCAST] - (Posted On Monday, November 23, 2020)
- Research Community Alert – NIH Finalizes Updated Data Sharing Policy - (Posted On Thursday, November 19, 2020)
- K&L Gates Triage: Eye on Election 2020: California v. Texas and the Future of the Affordable Care Act [PODCAST] - (Posted On Thursday, October 29, 2020)
- K&L Gates Triage: HIPAA: Do Hospitals Need a Business Associate Agreement with their Health System Parent Corporation? [PODCAST] - (Posted On Thursday, August 20, 2020)
- COVID-19: Updated - Planning for Life After 1135 Waivers and Other Regulatory Flexibility Ends - (Posted On Thursday, July 23, 2020)
- Motivations & Models for Health Systems Structuring Captive Venture Capital Investment Funds - (Posted On Tuesday, June 16, 2020)
- COVID-19: FCC Telehealth Program Funding for Health Care Providers - (Posted On Wednesday, April 22, 2020)